CCSD Code A3680: Excision of Cerebellopontine Angle Tumour

Key Takeaways

CCSD code A3680 covers the surgical excision of a cerebellopontine angle tumour, most commonly acoustic neuromas and meningiomas, in UK private practice.

Pre-authorisation is required by all major UK PMI providers before CCSD code A3680 can be submitted – obtain this before the procedure date.

ICD-10 codes D33.3 and C72.4 are the most clinically relevant diagnosis pairings for A3680; always confirm the specific histological classification with the operating consultant.

Claims for A3680 are submitted via Healthcode and must include operative notes, intraoperative monitoring records, and consultant-signed post-operative documentation.

Each insurer – Bupa, AXA Health, Aviva, Vitality, WPA, and Cigna – publishes its own fee schedule; never apply a single fee figure across multiple payers.

CCSD code A3680 sits within one of the most technically complex areas of UK private neurosurgery billing. The code covers the excision of a cerebellopontine angle (CPA) tumour – a procedure requiring specialist pre-authorisation, detailed intraoperative documentation, and careful diagnosis code pairing before any claim reaches an insurer’s adjudication desk. For billing administrators and private practice managers, getting this right is not simply a revenue issue; inaccurate or incomplete claims for high-value neurosurgical procedures are among the most common sources of delayed settlement and formal dispute in UK private healthcare.

This guide covers everything a neurosurgical billing team needs to handle CCSD code A3680 accurately: the procedure definition, clinical indications, ICD-10 diagnosis code pairings, documentation requirements, pre-authorisation workflows, and insurer-specific considerations for the major UK PMI providers. The CCSD classification is maintained by the CCSD governing body, whose published schedule and technical guide are the definitive references for all UK private procedure billing.

CCSD Code A3680: Procedure Description and Clinical Indications

The cerebellopontine angle is a wedge-shaped subarachnoid space at the junction of the cerebellum, pons, and petrous temporal bone. It contains cranial nerves VII and VIII, along with the anterior inferior cerebellar artery. Tumours arising here are not common – estimates suggest CPA tumours account for roughly 5-10% of all intracranial neoplasms – but they carry significant surgical complexity because of the proximity to critical neural and vascular structures.

CCSD Code A3680: What the Code Covers

CCSD code A3680 covers the surgical excision of a tumour arising within the cerebellopontine angle cistern. The code applies regardless of the specific surgical approach used – retrosigmoid, translabyrinthine, or middle fossa – because CCSD classifies by anatomical site and procedure type rather than the specific access route. Billing administrators should note that the approach chosen by the operating neurosurgeon affects documentation requirements but does not change the applicable CCSD code.

The code descriptor is precise: it applies to the excision procedure itself, not to diagnostic workup, stereotactic radiosurgery (such as Gamma Knife), or post-operative follow-up. Each of those stages carries its own CCSD code and must be billed separately. Conflating A3680 with radiosurgical or observation management is one of the most frequent coding errors seen in private neurosurgery billing.

CCSD Code A3680 Clinical Indications: Acoustic Neuromas and Meningiomas

Acoustic neuromas – more precisely termed vestibular schwannomas – and meningiomas are the two most common pathologies justifying CPA tumour excision. Vestibular schwannomas arise from the Schwann cells of the vestibulocochlear nerve and account for approximately 80-85% of all CPA tumours. Meningiomas of the CPA account for most of the remainder. Both may present with progressive unilateral sensorineural hearing loss, tinnitus, vestibular dysfunction, or – in larger tumours – facial nerve involvement and cerebellar compression symptoms.

Surgical excision via CCSD code A3680 is typically indicated when tumours exceed a certain size threshold, demonstrate growth on serial imaging, or produce symptomatic neural compression that conservative management cannot adequately control. The decision rests entirely with the consultant neurosurgeon. Billing administrators should not attempt to interpret clinical indication from imaging reports; the operative consent documentation and consultant pre-operative assessment letter provide the relevant clinical justification for the claim.

Private practices managing neurosurgical and complex surgical caseloads will recognise that procedure complexity at this level demands equally rigorous administrative processes. A single missing document can hold up settlement of a high-value claim for weeks.

CCSD Code A3680 ICD-10 Diagnosis Code Pairings

Every CCSD code A3680 claim submitted to a UK private medical insurer must be accompanied by one or more ICD-10 diagnosis codes that clinically justify the procedure. Insurers use these pairings to validate medical necessity; a claim submitted with a mismatched or incomplete diagnosis code is one of the most reliable routes to rejection. The relevant ICD-10 codes for CPA tumour excision are drawn from the international classification, with UK practices referring to the NHS Classifications Browser for the current UK edition.

CCSD Code A3680 ICD-10 Pairing: D33.3 (Benign Neoplasm of Cranial Nerves)

ICD-10 code D33.3 covers benign neoplasms of cranial nerves and is the most commonly applied diagnosis code when billing CCSD code A3680 for acoustic neuroma (vestibular schwannoma) excision. Because vestibular schwannomas are histologically benign, D33.3 aligns with the pathological classification and satisfies medical necessity criteria across most UK PMI providers. Confirm the histological report with the operating consultant before finalising the diagnosis code – where pathology is confirmed pre-operatively by imaging alone, the operating surgeon’s pre-operative assessment letter serves as the supporting clinical record.

CCSD Code A3680 ICD-10 Pairing: C72.4 (Malignant Neoplasm of Acoustic Nerve)

Where CPA tumour pathology is confirmed as malignant, ICD-10 code C72.4 – malignant neoplasm of the acoustic nerve – applies. This is less common in practice, as CPA malignancies are rare, but billing administrators must ensure the diagnosis code accurately reflects the confirmed pathology. Applying D33.3 to a claim involving a confirmed malignant lesion constitutes a coding inaccuracy that may trigger insurer audit. The NHS Classifications Browser provides the authoritative reference for UK ICD-10 code descriptions and hierarchy.

CCSD Code A3680 ICD-10 Pairing: H93.3 (Disorders of Acoustic Nerve)

ICD-10 code H93.3 covers disorders of the acoustic nerve and may be applied as a secondary diagnosis code where the primary indication for surgery is a vestibular schwannoma producing documented auditory or vestibular symptoms. In practice, H93.3 is more commonly seen as a secondary code alongside D33.3 to capture the functional impact driving the surgical decision. Discuss with the treating consultant whether the clinical picture warrants both a primary pathology code and a secondary functional code.

Always check each insurer’s provider guide for any insurer-specific restrictions on secondary diagnosis code submission. Some payers accept only a single diagnosis code per line item; others require full clinical context via secondary codes. Bupa’s CCSD coding guidance addresses this for Bupa-insured patients specifically.

CCSD Code A3680 Reference Table

The table below provides a quick reference for CCSD code A3680 billing administrators, covering the code descriptor, clinical context, primary and secondary ICD-10 pairings, and typical documentation required at submission. Verify current fee values with each insurer’s live fee schedule or fee finder, as fee schedules are updated periodically and figures are not reproduced here.

Documentation Requirements for CCSD Code A3680 Claims

Documentation quality is the single biggest determinant of whether a CCSD code A3680 claim settles on first submission. Neurosurgical procedures at this complexity level attract heightened scrutiny from insurer medical reviewers – particularly because the procedures are high-value and involve clinical decision-making that reviewers will want to see clearly evidenced in the submitted record.

Pre-Operative Documentation for CCSD Code A3680

The pre-operative documentation package for an A3680 claim should include a consultant neurosurgeon’s pre-operative assessment letter confirming the diagnosis, the surgical indication, and the planned approach. This letter establishes the clinical necessity that the insurer’s medical reviewer will evaluate. Where pre-authorisation has been granted, the authorisation reference number must appear on the invoice and claim form. Imaging reports – typically MRI with gadolinium contrast – provide the radiological evidence supporting the diagnosis code applied.

Consent documentation must also be included or available for audit. Under GMC guidance, neurosurgical consent for a procedure of this complexity requires documented discussion of risks including hearing loss, facial nerve injury, balance dysfunction, and cerebrospinal fluid leak. Where the patient’s primary language is not English, the consent process documentation should note the steps taken to ensure comprehension. Practices managing compliance workflows across multiple consultants will find that digital consent systems significantly reduce the risk of incomplete documentation at claim submission.

Intraoperative Documentation for CCSD Code A3680

Facial nerve monitoring is standard practice during CPA tumour excision and generates an intraoperative monitoring record that should be retained as part of the operative documentation. Insurers may request this as evidence that standard-of-care neuromonitoring was employed. The operative note itself must describe the approach used (retrosigmoid, translabyrinthine, or middle fossa), the degree of resection achieved (total, near-total, or subtotal), and any intraoperative complications. A detailed operative note is not optional for a high-complexity procedure coded under A3680 – its absence at audit will create settlement risk.

Post-Operative Documentation for CCSD Code A3680

Post-operative documentation requirements vary by insurer, but at a minimum the claim package should include a post-operative consultation note, the histopathology report confirming tumour type, and any inpatient nursing or HDU/ITU records where the patient required post-operative high-dependency care. Where an assistant surgeon was present, their involvement should be documented separately; assistant surgeon codes must be billed independently of the primary A3680 code. Similarly, anaesthetic services require separate CCSD coding and cannot be bundled with the surgical fee. The CCSD Technical Guide (October 2025) contains the binding unbundling rules that govern how simultaneous procedures must be reported.

Manage Complex Surgical Claims Without the Paper Trail

Pabau's claims management tools help neurosurgical and specialist private practices keep documentation complete, track pre-authorisation status, and submit accurately coded claims through Healthcode – reducing the back-and-forth with insurers on high-value procedures.

Book a demo

CCSD Code A3680 Pre-Authorisation: Insurer Workflows

Pre-authorisation for CCSD code A3680 is not a formality – it is a hard requirement across every major UK PMI provider. Submitting a claim for CPA tumour excision without a valid authorisation reference is among the fastest routes to rejection, and retrospective authorisation requests for neurosurgical procedures are rarely approved. The authorisation must be obtained before the procedure date, and in most cases the insurer will specify the hospital, consultant, and procedure scope within the authorisation letter. Any deviation – such as a change of surgical approach requiring an additional code – should be communicated to the insurer before surgery where clinically possible.

CCSD Code A3680 Pre-Authorisation: Bupa

Bupa requires pre-authorisation for all inpatient neurosurgical procedures and applies its own fee schedule to CCSD code A3680. Consultants and billing administrators should submit the pre-authorisation request through the Bupa provider portal, including the referring GP or specialist letter, MRI imaging reports, and the consultant’s proposed management plan. Bupa’s medical team may request a peer review for high-complexity cranial procedures. Once authorisation is issued, the reference number is valid for a defined period – typically 90 days – after which reapplication is required if the procedure date changes. Check current fee levels via the Bupa code search portal.

CCSD Code A3680 Pre-Authorisation: AXA Health

AXA Health operates a specialist procedure code framework that maps to CCSD. Pre-authorisation requests for A3680 should be submitted through the AXA Health specialist forms portal, and the treating consultant must be AXA-recognised. AXA Health may apply benefit limits specific to the member’s policy schedule, which can affect the reimbursable amount even where the procedure is fully authorised. Billing administrators should confirm the patient’s benefit limits before quoting expected insurer reimbursement. Fee chapter references are available through the AXA Health specialist procedure codes portal.

CCSD Code A3680 Pre-Authorisation: Aviva, Vitality, WPA, and Cigna

Aviva, Vitality Health, WPA, and Cigna each publish CCSD-coded fee schedules and require pre-authorisation for neurosurgical procedures. The process is broadly consistent – submit the clinical referral documentation, imaging reports, and consultant plan – but each insurer applies its own fee schedule and benefit limits. Aviva’s procedure guidelines and fee schedule are published on their provider portal. Vitality operates a fee finder tool that allows code-specific lookup by CCSD code. WPA and Cigna maintain separate schedules that should be checked directly through their respective provider portals before quoting or invoicing. Do not assume fee parity across insurers; the same CCSD code A3680 may attract materially different reimbursement rates from different payers.

Practices running multi-insurer neurosurgical caseloads benefit from centralised claims management software that tracks authorisation status, submission dates, and settlement status per insurer across all active patients. Manual tracking across spreadsheets at this volume and complexity creates unacceptable audit risk.

Healthcode Submission and Common Rejection Reasons for CCSD Code A3680

Healthcode is the primary electronic claims platform for UK private healthcare billing and is the submission route for CCSD code A3680 claims with all major PMI providers. Claims submitted via Healthcode are validated against each insurer’s current fee schedule and coding rules before reaching the adjudication desk. Understanding where electronic validation typically fails for high-complexity neurosurgical codes saves administrative time and accelerates settlement.

Submitting CCSD Code A3680 via Healthcode

When submitting CCSD code A3680 via Healthcode, the invoice must include the correct CCSD code, the paired ICD-10 diagnosis code(s), the pre-authorisation reference number, the date of procedure, the consultant’s GMC number, the hospital or facility details, and the itemised fee. Each co-billing code – anaesthetic, assistant surgeon, post-operative follow-up – must appear as a separate line item. Submitting a lump-sum figure that conflates the surgical fee with ancillary service fees will fail Healthcode’s line-item validation. Healthcode’s own guidance documentation confirms this itemisation requirement, and private practices that integrate billing workflows with Pabau’s claims management functionality can structure invoices to meet these requirements consistently.

Common Rejection Reasons for CCSD Code A3680 Claims

The most frequent rejection reasons for A3680 claims break into four categories. First, missing or expired pre-authorisation – the claim arrives without a valid authorisation reference, or the reference has lapsed because the procedure date moved. Second, diagnosis code mismatch – the ICD-10 code submitted does not align with the confirmed pathology in the operative notes, creating a discrepancy that triggers manual review. Third, incomplete documentation – the operative note, histopathology report, or monitoring record is absent from the submission package, particularly when the insurer requests clinical evidence as part of the claim review process. Fourth, unbundling errors – ancillary services (anaesthesia, assistance, monitoring) are included in the A3680 fee line rather than billed as separate codes, conflicting with the CCSD Technical Guide’s unbundling requirements.

Each of these rejection reasons is preventable with a structured pre-submission checklist. Private practice billing teams managing specialist surgical caseloads will find that a systematic pre-submission review process reduces rejection rates materially compared with ad hoc claim preparation. The Private Healthcare Information Network (PHIN) publishes outcome and transparency data across UK private hospitals; practices monitoring their claim acceptance rates can benchmark performance against sector norms using PHIN data as a reference point.

Expert Picks

Need a complete guide to Bupa CCSD codes for your private practice? Bupa CCSD Codes covers Bupa’s procedure code framework, fee schedule structure, and submission requirements for UK private practice billing teams.

Looking for a broader reference on private healthcare billing compliance in the UK? Benefits of Private Practice outlines the operational and financial considerations for consultants building or managing a UK private practice.

Want to understand how CQC registration intersects with private surgical practice compliance? Care Quality Commission (CQC) Role explains how CQC regulation applies to private hospitals and independent surgical facilities in England.

Conclusion

CCSD code A3680 covers one of the most complex procedures encountered in UK private neurosurgical billing. Accurate application requires more than knowing the code descriptor: it demands the right ICD-10 diagnosis pairing, a valid pre-authorisation reference from the treating insurer, complete operative and histological documentation, and a correctly itemised Healthcode submission that respects CCSD unbundling rules. Each UK PMI provider – Bupa, AXA Health, Aviva, Vitality, WPA, and Cigna – applies its own fee schedule and may impose benefit limits that affect the final settlement figure.

Billing teams that build structured workflows around CCSD code A3680 – pre-authorisation checklists, documentation templates, and insurer-specific submission protocols – will consistently outperform those relying on case-by-case judgement. Given the value and clinical complexity of CPA tumour excision, the administrative standard must match the surgical one.

Reviewed against current CCSD schedule documentation, NHS Classifications Browser ICD-10 UK edition references, and published insurer provider guidelines for UK private healthcare billing.

Frequently Asked Questions